Insect cell-based expression and characterization of a single-chain variable antibody fragment directed against blood coagulation factor VIII

Weisser, 2009, Applications of single-chain variable fragment antibodies in therapeutics and diagnostics, Biotechnol. Adv., 27, 502, 10.1016/j.biotechadv.2009.04.004 Gilmartin, 2012, High-level secretion of recombinant monomeric murine and human single-chain Fv antibodies from Drosophila S2 cells, Protein Eng. Des. Sel., 25, 59, 10.1093/protein/gzr058 Verma, 1998, Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems, J. Immunol. Methods, 216, 165, 10.1016/S0022-1759(98)00077-5 van den Brink, 2001, Multiple VH genes are used to assemble human antibodies directed toward the A3–C1 domains of factor VIII, Blood, 97, 966, 10.1182/blood.V97.4.966 Fay, 2006, Factor VIII structure and function, Int. J. Hematol., 83, 103, 10.1532/IJH97.05113 Zhang, 2009, Factor VIII inhibitors: risk factors and methods for prevention and immune modulation, Clin. Rev. Allergy Immunol., 37, 114, 10.1007/s12016-009-8122-5 Mertens, 2008, Antagonists of Factor VIII Interaction with Low-Density Lipoprotein Receptor-Related protein, US Patent Limburg, 2005, An antibody fragment against factor VIII that inhibits factor VIII assembly with von willebrand factor and LDL receptor family members, J. Thromb. Haemostasis, 3, OR162 Meijer, 2007, The factor VIII C1 domain contributes to efficient LRP/LDL receptor binding, J. Thromb. Haemostasis, 5, P-M-040 Meems, 2009, Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity, Blood, 114, 3938, 10.1182/blood-2009-01-197707 Herczenik, 2011, Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain, J. Allergy Clin. Immunol. Meems, 2011, C1 domain residues Lys 2092 and Phe 2093 are of major importance for the endocytic uptake of coagulation factor VIII, Int. J. Biochem. Cell Biol., 43, 1114, 10.1016/j.biocel.2011.03.014 Terpe, 2006, Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems, Appl. Microbiol. Biotechnol., 72, 211, 10.1007/s00253-006-0465-8 Arbabi-Ghahroudi, 2005, Prokaryotic expression of antibodies, Cancer Metastasis Rev., 24, 501, 10.1007/s10555-005-6193-1 Mukherjee, 2004, Studies of single-chain antibody expression in quiescent Escherichia coli, Appl. Environ. Microbiol., 70, 3005, 10.1128/AEM.70.5.3005-3012.2004 Oelschlaeger, 2003, Identification of factors impeding the production of a single-chain antibody fragment in Escherichia coli by comparing in vivo and in vitro expression, Appl. Microbiol. Biotechnol., 61, 123, 10.1007/s00253-002-1190-6 Ye, 2008, High-level expression and characterization of an anti-VEGF165 single-chain variable fragment (scFv) by small ubiquitin-related modifier fusion in Escherichia coli, Appl. Microbiol. Biotechnol., 81, 311, 10.1007/s00253-008-1655-3 Berkmen, 2012, Production of disulfide-bonded proteins in Escherichia coli, Protein Expr. Purif., 82, 240, 10.1016/j.pep.2011.10.009 Chen, 2004, High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain, Biotechnol. Bioeng., 85, 463, 10.1002/bit.20014 Lobstein, 2012, Shuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm, Microb. Cell Fact., 11, 56, 10.1186/1475-2859-11-56 Georgiou, 2005, Preparative expression of secreted proteins in bacteria: status report and future prospects, Curr. Opin. Biotechnol., 16, 538, 10.1016/j.copbio.2005.07.008 Schier, 1995, In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library, Immunotechnology, 1, 73, 10.1016/1380-2933(95)00007-0 Lemeulle, 1998, Anti-digoxin scFv fragments expressed in bacteria and in insect cells have different antigen binding properties, FEBS Lett., 423, 159, 10.1016/S0014-5793(98)00029-5 Padiolleau-Lefevre, 2007, Expression and detection strategies for an scFv fragment retaining the same high affinity than Fab and whole antibody: Implications for therapeutic use in prion diseases, Mol. Immunol., 44, 1888, 10.1016/j.molimm.2006.09.035 Mahiouz, 1998, Expression of recombinant anti-E-selectin single-chain Fv antibody fragments in stably transfected insect cell lines, J. Immunol. Methods, 212, 149, 10.1016/S0022-1759(98)00007-6 Reavy, 2000, Expression of functional recombinant antibody molecules in insect cell expression systems, Protein Expr. Purif., 18, 221, 10.1006/prep.1999.1191 Sakamoto, 2010, Expression, purification, and characterization of anti-plumbagin single-chain variable fragment antibody in Sf9 insect cell, Hybridoma (Larchmt.), 29, 481, 10.1089/hyb.2010.0052 Shestopal, 2011, Expression of the light chain of coagulation factor VIII in insect cells, Blood, 118, 985, 10.1182/blood.V118.21.2269.2269 Sarafanov, 2004, High-throughput optimization of protein expression in the baculovirus system based on determination of relative expression efficiency of viral stocks, Anal. Biochem., 328, 98, 10.1016/j.ab.2003.11.028 Shibeko, 2012, Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids, Blood, 120, 891, 10.1182/blood-2011-11-393371 Gourley, 2011, Development of a continuous thrombin generation-based test to measure potency in factor VIII concentrates, ASH Annu. Meeting Abstracts, 118, 1206 Fadeeva, 2010, Thromboplastin immobilized on polystyrene surface exhibits kinetic characteristics close to those for the native protein and activates in vitro blood coagulation similarly to thromboplastin on fibroblasts, Biochemistry (Mosc.), 75, 734, 10.1134/S0006297910060088 Ovanesov, 2003, Effect of factor VIII on tissue factor-initiated spatial clot growth, Thromb. Haemost., 89, 235, 10.1055/s-0037-1613437 Burgess, 2009, Preparing a purification summary table, Methods Enzymol., 463, 29, 10.1016/S0076-6879(09)63004-4 Rosen, 1984, Assay of factor VIII: C with a chromogenic substrate, Scand. J. Haematol. Suppl., 40, 139 Langdell, 1953, Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure, J. Lab. Clin. Med., 41, 637 Maertens, 2010, Gene optimization mechanisms: a multi-gene study reveals a high success rate of full-length human proteins expressed in Escherichia coli, Protein Sci., 19, 1312, 10.1002/pro.408 Fath, 2011, Multiparameter RNA and codon optimization: a standardized tool to assess and enhance autologous mammalian gene expression, PLoS ONE, 6, e17596, 10.1371/journal.pone.0017596 Laroche, 1991, Characterization of a recombinant single-chain molecule comprising the variable domains of a monoclonal antibody specific for human fibrin fragment D-dimer, J. Biol. Chem., 266, 16343, 10.1016/S0021-9258(18)55303-5 Kretzschmar, 1996, High-level expression in insect cells and purification of secreted monomeric single-chain Fv antibodies, J. Immunol. Methods, 195, 93, 10.1016/0022-1759(96)00093-2 Todorovska, 2001, Design and application of diabodies, triabodies and tetrabodies for cancer targeting, J. Immunol. Methods, 248, 47, 10.1016/S0022-1759(00)00342-2 Holliger, 2005, Engineered antibody fragments and the rise of single domains, Nat. Biotechnol., 23, 1126, 10.1038/nbt1142